Details for New Drug Application (NDA): 071383
✉ Email this page to a colleague
NDA 071383 describes ORALONE, which is a drug marketed by Taro and is included in one NDA. Additional details are available on the ORALONE profile page.
The generic ingredient in ORALONE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
The generic ingredient in ORALONE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 071383
| Tradename: | ORALONE |
| Applicant: | Taro |
| Ingredient: | triamcinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071383
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | PASTE;DENTAL | Strength | 0.1% | ||||
| Approval Date: | Jul 6, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
